Australia markets closed

Altimmune, Inc. (ALT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.33-0.06 (-0.81%)
At close: 04:00PM EDT
7.21 -0.12 (-1.64%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 519.71M
Enterprise value 338.24M
Trailing P/E 1.82
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.04k
Price/book (mrq)3.01
Enterprise value/revenue 824.98
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 383.25%
S&P500 52-week change 326.14%
52-week high 314.84
52-week low 32.09
50-day moving average 38.06
200-day moving average 36.45

Share statistics

Avg vol (3-month) 33.66M
Avg vol (10-day) 32.82M
Shares outstanding 570.9M
Implied shares outstanding 671.48M
Float 870.34M
% held by insiders 10.78%
% held by institutions 163.34%
Shares short (15 May 2024) 423.06M
Short ratio (15 May 2024) 47.47
Short % of float (15 May 2024) 432.78%
Short % of shares outstanding (15 May 2024) 432.53%
Shares short (prior month 15 Apr 2024) 420.37M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 Sept 2018
Ex-dividend date 420 Jan 2017
Last split factor 21:30
Last split date 314 Sept 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-535,879.98%

Management effectiveness

Return on assets (ttm)-29.48%
Return on equity (ttm)-54.46%

Income statement

Revenue (ttm)410k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-76.20%
Gross profit (ttm)N/A
EBITDA -88.09M
Net income avi to common (ttm)-92.77M
Diluted EPS (ttm)-1.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)182.02M
Total cash per share (mrq)2.57
Total debt (mrq)552k
Total debt/equity (mrq)0.32%
Current ratio (mrq)16.55
Book value per share (mrq)2.44

Cash flow statement

Operating cash flow (ttm)-72.76M
Levered free cash flow (ttm)-45.06M